Research Solutions (RSSS) 10-K15 Sep 232023 FY Annual reportFinancial data

Company Profile

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
Document And Entity Information - USD ($)	Jun. 30, 2023	Sep. 08, 2023	Dec. 31, 2022
Document And Entity Information
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2023
Entity File Number	001-39256
Entity Registrant Name	RESEARCH SOLUTIONS, INC.
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	11-3797644
Entity Address, Address Line One	Address not applicable
Entity Address, City or Town	N/A
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	N/A
City Area Code	310
Local Phone Number	477-0354
Title of 12(b) Security	Common stock, $0.001 par value
Trading Symbol	RSSS
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		29,596,086
Entity Public Float			$ 44,570,844
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Entity Central Index Key	0001386301
Auditor Firm ID	572
Auditor Location	Los Angeles, California
Auditor Name	Weinberg and Company, P.A
Amendment Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Current assets:
Cash and cash equivalents	$ 13,545,333	$ 10,603,175
Accounts receivable, net of allowance of $85,015 and $94,144, respectively	6,153,063	5,251,545
Prepaid expenses and other current assets	400,340	276,026
Prepaid royalties	1,202,678	846,652
Total current assets	21,301,414	16,977,398
Other assets:
Property and equipment, net of accumulated depreciation of $881,908 and $840,996, respectively	70,193	47,985
Intangible assets, net of accumulated amortization of $747,355 and $723,036, respectively	462,068	0
Deposits and other assets	1,052	893
Total assets	21,834,727	17,026,276
Current liabilities:
Accounts payable and accrued expenses	8,079,516	6,604,032
Deferred revenue	6,424,724	5,538,526
Total current liabilities	14,504,240	12,142,558
Commitments and contingencies
Stockholders' equity:
Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock; $0.001 par value; 100,000,000 shares authorized; 29,487,508 and 27,075,648 shares issued and outstanding, respectively	29,487	27,076
Additional paid-in capital	29,941,873	28,072,855
Accumulated deficit	(22,522,649)	(23,094,272)
Accumulated other comprehensive loss	(118,224)	(121,941)
Total stockholders' equity	7,330,487	4,883,718
Total liabilities and stockholders' equity	$ 21,834,727	$ 17,026,276

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Consolidated Balance Sheets
Allowance for doubtful accounts	$ 85,015	$ 94,144
Accumulated depreciation property and equipment	881,908	840,996
Intangible assets, accumulated amortization	$ 747,355	$ 723,036
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	20,000,000	20,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	29,487,508	27,075,648
Common Stock, Shares, Outstanding	29,487,508	27,075,648

Consolidated Statements of Oper

Consolidated Statements of Operations and Other Comprehensive Income (Loss) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Revenue:
Total revenue	$ 37,703,452	$ 32,934,152
Cost of revenue:
Total cost of revenue	23,002,561	20,914,478
Gross profit	14,700,891	12,019,674
Operating expenses:
Selling, general and administrative	14,409,634	13,633,939
Depreciation and amortization	52,649	17,651
Total operating expenses	14,462,283	13,651,590
Income (loss) from operations	238,608	(1,631,916)
Other income	338,617	7,154
Income (loss) from operations before provision for income taxes	577,225	(1,624,762)
Provision for income taxes	(5,602)	(7,622)
Net income (loss)	571,623	(1,632,384)
Other comprehensive income (loss):
Foreign currency translation	3,717	(2,364)
Comprehensive income (loss)	$ 575,340	$ (1,634,748)
Income (loss) per common share:
Net income (loss) per share, basic	$ 0.02	$ (0.06)
Net income (loss) per share, diluted	$ 0.02	$ (0.06)
Weighted average common shares outstanding:
Weighted average common shares outstanding, basic	26,860,761	26,422,295
Weighted average common shares outstanding, diluted	29,139,759	26,422,295
Platforms
Revenue:
Total revenue	$ 8,683,246	$ 6,787,772
Cost of revenue:
Total cost of revenue	1,027,286	936,589
Transactions
Revenue:
Total revenue	29,020,206	26,146,380
Cost of revenue:
Total cost of revenue	$ 21,975,275	$ 19,977,889

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity	Common Stock USD ($) shares	Common Stock UYU ($) shares	Additional Paid-in Capital USD ($)	Accumulated Deficit USD ($)	Other Comprehensive Loss USD ($)	USD ($) shares
Balance at Jun. 30, 2021	$ 26,498		$ 26,982,052	$ (21,461,888)	$ (119,577)	$ 5,427,085
Balance (in shares) at Jun. 30, 2021 \| shares	26,498,215	26,498,215
Fair value of vested stock options	$ 0		470,615	0	0	470,615
Fair value of vested restricted common stock	$ 356		557,140	0	0	557,496
Fair value of vested restricted common stock (in shares) \| shares	356,582	356,582
Repurchase of common stock	$ (40)		(93,878)	0	0	$ (93,918)
Repurchase of common stock (in shares) \| shares	(40,221)	(40,221)				(40,221)
Common stock issued upon exercise of stock options	$ 212		97,476	0	0	$ 97,688
Common stock issued upon exercise of stock options (in shares) \| shares	211,072	211,072				357,079
Common stock issued upon exercise of warrants	$ 50		59,450	0	0	$ 59,500
Common stock issued upon exercise of warrants (in shares) \| shares	50,000	50,000
Net income (loss) for the period	$ 0		0	(1,632,384)	0	(1,632,384)
Foreign currency translation	0		0	0	(2,364)	(2,364)
Balance at Jun. 30, 2022	$ 27,076		28,072,855	(23,094,272)	(121,941)	4,883,718
Balance (in shares) at Jun. 30, 2022 \| shares	27,075,648	27,075,648
Fair value of vested stock options	$ 0		375,189	0	0	375,189
Fair value of vested restricted common stock	$ 2,355		1,416,363	0	0	1,418,718
Fair value of vested restricted common stock (in shares) \| shares	2,354,834	2,354,834
Repurchase of common stock	$ (52)		(104,198)	0	0	$ (104,250)
Repurchase of common stock (in shares) \| shares	(51,841)	(51,841)				(51,841)
Forfeited restricted common stock	$ (65)		65	0	0	$ 0
Forfeited restricted common stock (in shares) \| shares	(65,165)	(65,165)
Fair value of vested unrestricted common stock	$ 36		68,236	0	0	68,272
Fair value of vested unrestricted common stock (in shares) \| shares	36,509	36,509
Common stock issued upon exercise of stock options	$ 137		57,363	0	0	$ 57,500
Common stock issued upon exercise of stock options (in shares) \| shares	137,523	137,523				307,298
Modification cost of stock options	$ 0	$ 0	56,000	0	0	$ 56,000
Net income (loss) for the period	0		0	571,623	0	571,623
Foreign currency translation	0		0	0	3,717	3,717
Balance at Jun. 30, 2023	$ 29,487		$ 29,941,873	$ (22,522,649)	$ (118,224)	$ 7,330,487
Balance (in shares) at Jun. 30, 2023 \| shares	29,487,508	29,487,508

Consolidated Statements of Cash

Consolidated Statements of Cash Flows	12 Months Ended
Consolidated Statements of Cash Flows	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)
Cash flow from operating activities:
Net income (loss)	$ 571,623	$ (1,632,384)
Adjustment to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	52,649	17,651
Fair value of vested stock options	375,189	470,615
Fair value of vested restricted common stock	1,418,718	557,496
Fair value of vested unrestricted common stock	68,272	0
Modification cost of stock options	56,000	0
Changes in operating assets and liabilities:
Accounts receivable	(901,518)	(534,092)
Prepaid expenses and other current assets	(124,314)	(5,774)
Prepaid royalties	(356,026)	58,269
Accounts payable and accrued expenses	1,337,056	(83,156)
Deferred revenue	886,198	734,175
Net cash provided by (used in) operating activities	3,383,847	(417,200)
Cash flow from investing activities:
Purchase of property and equipment	(47,209)	(44,288)
Payment for non-refundable deposit for asset acquisition	(297,450)	0
Net cash used in investing activities	(344,659)	(44,288)
Cash flow from financing activities:
Proceeds from the exercise of stock options	57,500	97,688
Proceeds from the exercise of warrants	0	59,500
Common stock repurchase	(104,250)	(93,918)
Payment of contingent acquisition consideration	(50,509)	0
Net cash provided by (used in) financing activities	(97,259)	63,270
Effect of exchange rate changes	229	(2,944)
Net increase (decrease) in cash and cash equivalents	2,942,158	(401,162)
Cash and cash equivalents, beginning of period	10,603,175	11,004,337
Cash and cash equivalents, end of period	13,545,333	10,603,175
Supplemental disclosures of cash flow information:
Cash paid for income taxes	5,602	7,622
Non-cash investing and financing activities:
Contingent consideration accrual on asset acquisition	$ 138,428	$ 0

Organization, Nature of Busines

Organization, Nature of Business and Basis of Presentation	12 Months Ended
Organization, Nature of Business and Basis of Presentation	Jun. 30, 2023
Organization, Nature of Business and Basis of Presentation
Organization, Nature of Business and Basis of Presentation	Note 1. Organization, Nature of Business and Basis of Presentation Organization Research Solutions, Inc. (the “Company,” “Research Solutions,” “we,” “us” or “our”) was incorporated in the State of Nevada on November 2, 2006, and is a publicly traded holding company with three wholly owned subsidiaries as of June 30, 2023: Reprints Desk, Inc., a Delaware corporation, Reprints Desk Latin America S. de R.L. de C.V, an entity organized under the laws of Mexico, and RESSOL LA, S. DE R.L. DE C.V., an entity organized under the laws of Mexico. Nature of Business We provide two service offerings to our customers: a cloud-based software-as-a-service (“SaaS”) research platform (“Platforms”) typically sold via annual auto-renewing license agreements and the sale of published scientific, technical, and medical (“STM”) content sold as individual articles (“Transactions”) either stand alone or via the Platform. When customers utilize the Platform to purchase Transactions it is packaged as a single solution that enables life science and other research-intensive organizations to accelerate their research and development activities with faster, access and management of STM articles used throughout the intellectual property development lifecycle. The Platform typically delivers a ROI to the customer via more effectively managing Transaction costs and saving researchers time during the research process. Platforms Our cloud-based SaaS research Platform consists of proprietary software and Internet-based interfaces sold to customers for an annual subscription fee. Legacy functionality allows customers to initiate orders, route orders for the lowest cost acquisition, manage transactions, obtain spend and usage reporting, automate authentication, and connect seamlessly to in-house and third-party software systems. Customers can also enhance the information resources they already own or license and collaborate around bibliographic information. Additional functionality has recently been added to our Platform in the form of interactive app-like components. An alternative to manual data filtering, identification and extraction, the apps are designed to gather, augment, and extract data across a variety of formats, including bibliographic citations, tables of contents, RSS feeds, PDF files, XML feeds, and web content. We continue to develop new apps in order to build an ecosystem of apps. Together, these apps will provide researchers with an “all in one” toolkit, delivering efficiencies in core research workflows and knowledge creation processes. Our Platform is deployed as a single, multi-tenant system across our entire customer base. Customers securely access the Platform through online web interfaces and via web service APIs that enable customers to leverage Platform features and functionality from within in-house and third-party software systems. The Platform can also be configured to satisfy a customer’s individual preferences. We leverage our Platform’s efficiencies in scalability, stability and development costs to fuel rapid innovation and competitive advantage. Transactions Our Platform provides our customers with a single source to the universe of published STM content that includes over 80 million existing STM articles and over one million newly published STM articles each year. STM content is sold to our customers on a transaction basis. Researchers and knowledge workers in life science and other research-intensive organizations generally require single copies of published STM journal articles for use in their research activities. These individuals are our primary users. Our Platform allows customers to find and download digital versions of STM articles that are critical to their research. Customers submit orders for the articles they need which we source and electronically deliver to them generally in under an hour; in many cases under one minute. This service is generally known in the industry as single article delivery or document delivery. We also obtain the necessary permission licenses from the content publisher or other rights holder so that our customer’s use complies with applicable copyright laws. We have arrangements with hundreds of content publishers that allow us to distribute their content. The majority of these publishers provide us with electronic access to their content, which allows us to electronically deliver single articles to our customers often in a matter of minutes. Principles of Consolidation The accompanying financial statements are consolidated and include the accounts of the Company and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Jun. 30, 2023
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies Use of Estimates The preparation of financial statements in conformity with Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. These estimates and assumptions include estimates for reserves of uncollectible accounts, accruals for potential liabilities, assumptions made in valuing equity instruments issued for services or acquisitions, and realization of deferred tax assets. Cash and Cash Equivalents For purposes of the statements of cash flows, the Company defines cash equivalents as all highly liquid debt instruments purchased with an original maturity of three months or less. In all periods presented, cash equivalents consist primarily of money market funds. Fair Value of Financial Instruments Under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Inputs, other than the quoted prices in active markets, are observable either directly or indirectly. Level 3 – Unobservable inputs based on the Company’s assumptions. The Company is required to use observable market data if such data is available without undue cost and effort. The Company has no fair value items required to be disclosed as of June 30, 2023 or 2022 under these requirements. The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable and accounts payable, approximate their fair values because of the short maturity of these instruments. Allowance for Doubtful Accounts The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded, which reduces the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential bad debts, bad debt charges are recorded based on the Company’s historical losses and an overall assessment of past due trade accounts receivable outstanding. The Company established an allowance for doubtful accounts of $85,015 and $94,144 as of June 30, 2023 and 2022, respectively. Concentration of Credit Risk Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents and accounts receivable. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $250,000 insurance limit. The Company does not anticipate incurring any losses related to these credit risks. The Company extends credit based on an evaluation of the customer’s financial condition, generally without collateral. Exposure to losses on receivables is principally dependent on each customer’s financial condition. The Company monitors its exposure for credit losses and intends to maintain allowances for anticipated losses, as required. Cash denominated in Euros and British Pounds with an aggregate US Dollar equivalent of $1,760,323 and $483,232 at June 30, 2023 and 2022, respectively, was held in accounts at financial institutions located in Europe. The Company has no customers that represent 10% of revenue or more for the years ended June 30, 2023 and 2022. The Company has no customers that represent 10% of accounts receivable at June 30, 2023 and 2022. The following table summarizes our content costs from our vendors: Year Ended June 30, 2023 2022 Vendor A 23 % 21 % Vendor B 13 % 13 % Property and Equipment Property and equipment are stated at cost and are depreciated using the straight-line method over their estimated useful lives of 3 to 7 years. Leasehold improvements are amortized over the shorter of the useful lives of the related assets, or the lease term. Expenditures for maintenance and repairs are charged to operations as incurred while renewals and betterments are capitalized. Gains and losses on disposals are included in the consolidated statements of operations. Management assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended June 30, 2023 and 2022, the Company did not recognize any impairments for its property and equipment. Revenue Recognition The Company accounts for revenue in accordance with ASU 2014-09, Revenue from Contracts with Customers (Topic 606), (“ASC 606”). The underlying principle of ASC 606 is to recognize revenue to depict the transfer of goods or services to customers at the amount expected to be collected. Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company derives its revenues from two sources: annual licenses that allow customers to access and utilize certain premium features of our cloud-based SaaS research intelligence platform (“Platforms”) and the transactional sale of STM content managed, sourced and delivered through the Platform (“Transactions”). The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements: ● identify the contract with a customer; ● identify the performance obligations in the contract; ● determine the transaction price; ● allocate the transaction price to performance obligations in the contract; and ● recognize revenue as the performance obligation is satisfied. Platforms We charge a subscription fee that allows customers to access and utilize certain premium features of our Platform. Revenue is recognized ratably over the term of the subscription agreement, which is typically one year, provided all other revenue recognition criteria have been met. Billings or payments received in advance of revenue recognition are recorded as deferred revenue. Transactions We charge a transactional service fee for the electronic delivery of single articles, and a corresponding copyright fee for the permitted use of the content. We recognize revenue from single article delivery services upon delivery to the customer provided all other revenue recognition criteria have been met. Revenue by Geographical Region The following table summarizes revenue by geographical region: Year Ended June 30, 2023 2022 United States $ 21,862,582 58.0 % $ 19,170,684 58.2 % Europe 12,716,650 33.7 % 11,432,516 34.7 % Rest of World 3,124,220 8.3 % 2,330,952 7.1 % Total $ 37,703,452 100 % $ 32,934,152 100 % Accounts Receivable by Geographical Region The following table summarizes accounts receivable by geographical region: Year Ended June 30, 2023 2022 United States $ 3,727,977 60.6 % $ 3,255,976 62.0 % Europe 1,763,044 28.7 % 1,665,111 31.7 % Rest of World 662,042 10.8 % 330,458 6.3 % Total $ 6,153,063 100 % $ 5,251,545 100 % Cost of Revenue Platforms Cost of Platform revenue consists primarily of personnel costs of our operations team, and to a lesser extent managed hosting providers and other third-party service and data providers. Transactions Cost of Transaction revenue consists primarily of the respective copyright fee for the permitted use of the content, less a discount in most cases, and to a much lesser extent, personnel costs of our operations team and third-party service providers. Stock-Based Compensation The Company periodically issues stock options, warrants and restricted stock to employees and non-employees for services, in capital raising transactions, and for financing costs. The Company accounts for share-based payments under the guidance as set forth in the Share-Based Payment Topic 718 of the FASB Accounting Standards Codification, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, officers, directors, and consultants, including employee stock options, based on estimated fair values. The Company estimates the fair value of stock option and warrant awards to employees and directors on the date of grant using an option-pricing model, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company’s Statements of Operations. The Company estimates the fair value of restricted stock awards to employees and directors using the market price of the Company’s common stock on the date of grant, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company’s Statements of Operations. Under ASC 718, Repurchase or Cancellation of equity awards, the amount of cash or other assets transferred (or liabilities incurred) to repurchase an equity award shall be charged to equity, to the extent that the amount paid does not exceed the fair value of the equity instruments repurchased at the repurchase date. Any excess of the repurchase price over the fair value of the instruments repurchased shall be recognized as additional compensation cost. Foreign Currency The accompanying consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the period. Although the majority of our revenue and costs are in US dollars, the costs of Reprints Desk Latin America and ResSoL LA are in Mexican Pesos. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities. Gains and losses from foreign currency transactions, which result from a change in exchange rates between the functional currency and the currency in which a foreign currency transaction is denominated, are included in selling, general and administrative expenses and amounted to a gain of $121,953 and a loss of $143,898 for the years ended June 30, 2023 and 2022, respectively. Cash denominated in Euros and British Pounds with an aggregate US Dollar equivalent of $1,760,323 and $483,232 at June 30, 2023 and 2022, respectively, was held in accounts at financial institutions located in Europe. The following table summarizes the exchange rates used: Year Ended June 30, 2023 2022 Period end Euro : US Dollar exchange rate 1.09 1.05 Average period Euro : US Dollar exchange rate 1.05 1.13 Period end GBP : US Dollar exchange rate 1.27 1.21 Average period GBP : US Dollar exchange rate 1.20 1.34 Period end Mexican Peso : US Dollar exchange rate 0.06 0.05 Average period Mexican Peso : US Dollar exchange rate 0.05 0.05 Net Income (Loss) Per Share Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive. At June 30, 2023 potentially dilutive securities include options to acquire 2,909,574 shares of common stock and unvested restricted common stock of 2,477,794. At June 30, 2022 potentially dilutive securities include options to acquire 3,182,872 shares of common stock and unvested restricted common stock of 400,092. The dilutive effect of potentially dilutive securities is reflected in diluted net income per share if the exercise prices were lower than the average fair market value of common shares during the reporting period. Basic and diluted net loss per common share is the same for the year ended June 30, 2022 because all stock options, warrants, and unvested restricted common stock are anti-dilutive. For the year ended June 30, 2023, the calculation of diluted earnings per share include unvested restricted common stock, stock options and warrants, calculated under the treasury stock method. Income Taxes The Company accounts for income taxes using the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Recently Issued Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses (“CECL”) to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. ASU 2016-13 is effective for the Company beginning July 1, 2023, and early adoption is permitted. The Company does not believe the potential impact of the new guidance and related codification improvements will be material to its financial position, results of operations and cash flows. Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

Property and Equipment

Property and Equipment	12 Months Ended
Property and Equipment	Jun. 30, 2023
Property and Equipment
Property and Equipment	Note 3. Property and Equipment Property and equipment consists of the following as of June 30, 2023 and 2022: June 30, June 30, 2023 2022 Computer equipment $ 628,200 $ 566,518 Software 282,080 282,080 Furniture and fixtures 41,821 40,383 Total 952,101 888,981 Less accumulated depreciation (881,908) (840,996) Net, Property and equipment $ 70,193 $ 47,985 Depreciation expense for the years ended June 30, 2023 and 2022 was $28,329 and $17,651, respectively.

Intangible Assets

Intangible Assets	12 Months Ended
Intangible Assets	Jun. 30, 2023
Intangible Assets
Intangible Assets	Note 4. Intangible Assets Intangible assets consist of customer lists, which are amortized over an estimated useful life of ten years. The Company does not have any intangible assets deemed to have indefinite lives. Amortization expense for the years ended June 30, 2023 and 2022 was $24,320 and $0, respectively. Amortization expense expected to be recognized is approximately $49,000 annually in 2024 through 2028 and approximately $217,000 thereafter. Intangible assets consist of the following as of June 30, 2023 and 2022: June 30, June 30, 2023 2022 Customer lists $ 1,192,998 $ 706,611 Intellectual property licenses 16,425 16,425 Total 1,209,423 723,036 Less accumulated amortization (747,355) (723,036) Net, Intangible assets $ 462,068 $ —

Line of Credit

Line of Credit	12 Months Ended
Line of Credit	Jun. 30, 2023
Line of Credit
Line of Credit	Note 5 . The Company entered into a Loan and Security Agreement with Silicon Valley Bank (“SVB”) on July 23, 2010, which, as amended, provides for a revolving line of credit for the lesser of $2,500,000, or 80% of eligible accounts receivable. The line of credit matures on February 28, 2024, and is subject to certain financial and performance covenants with which we were in compliance as of June 30, 2023. Financial covenants include maintaining an adjusted quick ratio of unrestricted cash and net accounts receivable, divided by current liabilities plus debt less deferred revenue of at least 1.15 to 1.0. The line of credit bears interest at an annual rate equal to the greater of 1% above the prime rate and 5.0%. The interest rate on the line of credit was 9.25% as of June 30, 2023. The line of credit is secured by the Company’s consolidated assets. Pursuant to the Amended and Restated Loan and Security Agreement dated October 31, 2017 among the Company, Reprints Desk, Inc. and SVB (the “SVB LSA”), the Company was required to direct account debtors to deliver or transmit all proceeds of accounts remitted to the Company and its subsidiaries into a lockbox account as specified by SVB, and to maintain its and its subsidiaries’ primary operating and other deposit accounts with SVB. In compliance with the foregoing covenants the Company and its subsidiaries maintained with SVB substantially all of the dollar value of the Company’s and its subsidiaries’ accounts. At February 28, 2023, the Company held cash at SVB of $10,832,000, of which we estimate $9,738,000 was in excess of government insured limits. On March 10, 2023, SVB was closed by the California Department of Financial Protection and Innovation, and the Federal Deposit Insurance Corporation (“FDIC”) was appointed as receiver and SVB was subsequently transferred into a new entity, Silicon Valley Bridge Bank, N.A. (“SVB Bridge Bank”). On March 12, 2023, the U.S. Treasury Department, the Federal Reserve and the FDIC jointly announced enabling actions that fully protect all SVB depositors’ insured and uninsured deposits, and that such depositors would have access to all of their funds starting March 13, 2023. On March 14, 2023, the Company was able to access its full deposits with SVB Bridge Bank. At June 30, 2023, the Company held cash at SVB Bridge Bank of $7,580,000, of which we estimate $6,443,000 was in excess of government insured limits. There were no outstanding borrowings under the line as of June 30, 2023 and June 30, 2022, respectively. As of June 30, 2023, there was approximately $2,264,000 of available credit. On March 27, 2023, First Citizens BancShares, Inc entered into an agreement with the Federal Deposit Insurance Corporation (FDIC) to purchase all of the assets and liabilities of SVB. The Company has confirmed that the Loan and Security Agreement remains in effect post this transaction and that, in addition to having access to all of its deposits with SVB, it continues to have access to the revolving line of credit. SVB Bridge Bank agreed that the Company can lower its cash balance threshold requirement associated with the SVB LSA, reducing the required balances of its and its subsidiaries’ primary operating and other accounts with SVB, and the Company continues to evaluate the SVB LSA. At June 30, 2023, the Company also held cash at Bank of America, N.A. of $1,500,000 and at PNC Bank, N.A. of $4,448,000. The Company continues to re-allocate its cash position across all three banks and explore an overall banking diversification strategy as well as additional access to lending facilities.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
Stockholders' Equity	Jun. 30, 2023
Stockholders' Equity
Stockholders' Equity	Note 6. Stockholders’ Equity Stock Options In December 2007, we established the 2007 Equity Compensation Plan (the “2007 Plan”) and in November 2017 we established the 2017 Omnibus Incentive Plan (the “2017 Plan”), collectively (the “Plans”). The Plans were approved by our board of directors and stockholders. The purpose of the Plans is to grant stock and options to purchase our common stock, and other incentive awards, to our employees, directors and key consultants. On November 10, 2016, the maximum number of shares of common stock that may be issued pursuant to awards granted under the 2007 Plan increased from 5,000,000 to 7,000,000. On November 21, 2017, the Company’s stockholders approved the adoption of the 2017 Plan (previously adopted by our board of directors on September 14, 2017), which authorized a maximum of 1,874,513 shares of common stock that may be issued pursuant to awards granted under the 2017 Plan. On November 17, 2020, the Company’s stockholders approved an increase in the maximum number of shares of common stock that may be issued pursuant to awards granted under the 2017 Omnibus Incentive Plan from 2,374,513 to 3,374,513. On November 17, 2021, the Company's stockholders approved an increase in the maximum number of shares of common stock that may be issued pursuant to awards granted under the 2017 Omnibus Incentive Plan from 3,374,513 to 6,874,513. Upon adoption of the 2017 Plan we ceased granting incentive awards under the 2007 Plan and commenced granting incentive awards under the 2017 Plan. The shares of our common stock underlying cancelled and forfeited awards issued under the 2017 Plan may again become available for grant under the 2017 Plan. Cancelled and forfeited awards issued under the 2007 Plan that were cancelled or forfeited prior to November 21, 2017 became available for grant under the 2007 Plan. As of June 30, 2023, there were 1,495,927 shares available for grant under the 2017 Plan, and no shares were available for grant under the 2007 Plan. All incentive stock award grants prior to the adoption of the 2017 Plan on November 21, 2017 were made under the 2007 Plan, and all incentive stock award grants after the adoption of the 2017 Plan on November 21, 2017 were made under the 2017 Plan. The majority of awards issued under the Plan vest immediately or over three years, with a one year cliff vesting period, and have a term of ten years. Stock-based compensation cost is measured at the grant date, based on the fair value of the awards that are ultimately expected to vest, and recognized on a straight-line basis over the requisite service period, which is generally the vesting period. The following table summarizes vested and unvested stock option activity: All Options Vested Options Unvested Options Weighted Weighted Weighted Average Average Average Exercise Exercise Exercise Shares Price Shares Price Shares Price Outstanding at July 1, 2021 3,258,408 $ 1.68 2,930,474 $ 1.60 327,934 $ 2.46 Granted 307,843 2.22 — — 307,843 2.22 Options vesting — — 452,879 2.26 (452,879) 2.26 Exercised (357,079) 1.20 (357,079) 1.20 — — Forfeited (26,300) 1.34 (26,300) 1.34 — — Outstanding at June 30, 2022 3,182,872 $ 1.79 2,999,974 $ 1.75 182,898 $ 2.49 Granted 200,000 2.15 — — 200,000 2.15 Options vesting — — 336,834 2.28 (336,834) 2.28 Exercised (307,298) 1.31 (307,298) 1.31 — — Forfeited (166,000) 1.81 (163,917) 1.79 (2,083) 3.92 Outstanding at June 30, 2023 2,909,574 $ 1.87 2,865,593 $ 1.86 43,981 $ 2.47 The following table presents the assumptions used to estimate the fair values based upon a Black-Scholes option pricing model of the stock options granted during the years ended June 30, 2023 and 2022. Years Ended June 30, 2023 2022 Expected dividend yield — % — % Risk-free interest rate 3.76 % 0.92 - 1.81 % Expected life (in years) 5 5 - 6 Expected volatility 56 % 56 % The weighted average remaining contractual life of all options outstanding as of June 30, 2023 was 5.49 years. The remaining contractual life for options vested and exercisable at June 30, 2023 was 5.45 years. Furthermore, the aggregate intrinsic value of options outstanding and of options vested and exercisable at June 30, 2023 was $1,096,942, in each case based on the fair value of the Company’s common stock on June 30, 2023. During the year ended June 30, 2023, the Company granted 200,000 options to directors with a fair value of $222,000 which, due to immediate vesting, were fully expensed at the time of grant. The total fair value of options that vested during the year ended June 30, 2023 was $375,189 and was included in selling, general and administrative expenses in the accompanying statement of operations. As of June 30, 2023, the amount of unvested compensation related to the unvested options was $56,577 which will be recorded as an expense in future periods as the options vest. During the year ended June 30, 2023, the Company issued 137,523 net shares of common stock upon the exercise of options underlying 307,298 shares of common stock, resulting in net cash proceeds of $57,500. During the year ended June 30, 2022, the Company granted 307,843 options to employees with a fair value of $342,566 which amount will be amortized over the vesting period. The total fair value of options that vested during the year ended June 30, 2022 was $470,615 and was included in selling, general and administrative expenses in the accompanying statement of operations. As of June 30, 2022, the amount of unvested compensation related to the unvested options was $212,642 which will be recorded as an expense in future periods as the options vest. During the year ended June 30, 2022, the Company issued 211,072 net shares of common stock upon the exercise of options underlying 357,079 shares of common stock, resulting in net cash proceeds of $97,688. Additional information regarding stock options outstanding and exercisable as of June 30, 2023 is as follows: Option Remaining Exercise Options Contractual Options Price Outstanding Life (in years) Exercisable $ 0.70 225,000 2.43 225,000 0.77 25,000 1.14 25,000 0.80 16,000 2.14 16,000 0.90 15,000 2.10 15,000 1.00 15,000 1.70 15,000 1.05 305,000 3.15 305,000 1.09 40,000 2.90 40,000 1.10 105,000 2.00 105,000 1.20 274,000 4.05 274,000 1.59 25,000 4.87 25,000 1.80 54,550 0.23 54,550 1.95 200,000 5.01 200,000 2.10 238,767 8.62 238,767 2.13 216,708 7.39 215,316 2.15 200,000 9.45 200,000 2.17 35,955 7.87 26,965 2.19 5,000 8.56 2,500 2.40 302,833 5.38 302,833 2.43 61,250 7.93 53,750 2.45 163,000 7.10 163,000 2.49 78,435 6.92 76,195 2.50 20,000 5.88 20,000 2.64 30,882 8.10 20,588 2.67 33,194 8.22 22,129 2.99 8,000 6.87 8,000 3.13 208,000 6.38 208,000 3.50 8,000 6.62 8,000 Total 2,909,574 2,865,593 Warrants The following table summarizes warrant activity: Weighted Average Number of Exercise Warrants Price Outstanding, June 30, 2021 50,000 $ 1.19 Granted — — Exercised (50,000) 1.19 Repurchased — — Expired/Cancelled — — Outstanding, June 30, 2022 — $ — Granted — — Exercised — — Repurchased — — Expired/Cancelled — — Outstanding, June 30, 2023 — $ — Exercisable, June 30, 2022 — $ — Exercisable, June 30, 2023 — $ — During the year ended June 30, 2022, certain holders of warrants to purchase shares of the Company’s common stock at a per share exercise price of $1.19 exercised those warrants to purchase 50,000 shares, generating gross proceeds to the Company of $59,500. Restricted Common Stock Prior to July 1, 2021, the Company issued 2,473,176 shares of restricted common stock to employees valued at $2,985,198, of which $2,503,245 had been recognized as an expense. As of June 30, 2021, 245,252 of these shares with a grant date fair value of $481,953 had not yet vested. During the year ended June 30, 2022, the Company issued an additional 356,582 shares of restricted stock to employees. Of this amount, 256,582 shares vest over a three year period, with a one year cliff vesting period, and remain subject to forfeiture if vesting conditions are not met. The remaining 100,000 shares vest over a four year period, with a one year cliff vesting period, and remain subject to forfeiture if vesting conditions are not met. The aggregate fair value of the stock awards was $850,996 based on the market price of our common stock ranging from $1.87 to $2.64 per share on the date of grant, which will be amortized over the vesting period. During the year ended June 30, 2023, the Company issued an additional 2,354,834 shares of restricted stock to employees with an aggregate fair value of $3,478,878. Of this amount, 229,834 shares vest over a three year period, with a one year cliff vesting period, and remain subject to forfeiture if vesting conditions are not met and 25,000 shares vest over a four year period, with a one year cliff vesting period, and remain subject to forfeiture if vesting conditions are not met. The aggregate fair value of these stock awards was $503,478 based on the market price of our common stock price ranging from $1.94 to $2.22 per share on the date of grant, which will be amortized over the range of three Upon a change of control vesting will accelerate with respect to that portion of the award that would vest if the target 30-day VWAP was achieved at the level above the per share price in such change of control transaction. For example, if we granted an award of 100,000 shares under the LTEBP, 20,000 shares would vest upon our stock price achieving a 30-day VWAP of $3.00 per share, and 20,000 shares would vest upon our stock price achieving a 30-day VWAP of $3.75 per share. If the per share price in a change of control transaction was $5.00 per share, vesting would accelerate for 40,000 shares under the same award (i.e. the number of shares that would vest for our stock price achieving a 30-day VWAP of $5.25 per share, pursuant to a tier round up provision in the Plan effective upon a change in control). As a condition to receiving awards under the LTEBP, recipients will be required to hold at least 75% of all vested shares during the term of their employment. Applicable target 30-day VWAPs must be achieved within 5 years following the grant of awards under the LTEBP, and all unvested awards under the LTEBP will be forfeited upon expiration of such 5-year As the vesting of the 2,100,000 shares of restricted common stock under the LTEBP is subject to certain market conditions, pursuant to current accounting guidelines, the Company determined the fair value to be $2,975,400, computed using the Monte Carlo simulations on a binomial model with the assistance of a valuation specialist with a derived service period ranging from 1.36 to 2.59 years. The total fair value of restricted common stock vesting and expenses related to amortization of the fair value of the LTEBP program during the year ended June 30, 2023 was $1,418,717 and is included in selling, general and administrative expenses in the accompanying statements of operations. As of June 30, 2023, the amount of unvested compensation related to issuances of restricted common stock was $2,711,661, which will be recognized as an expense in future periods as the shares vest. When calculating basic net income per share, these shares are included in weighted average common shares outstanding from the time they vest. When calculating diluted net income per share, these shares are included in weighted average common shares outstanding as of their grant date. When calculating net loss per share, the 2,477,794 shares are considered antidilutive and are excluded from that calculation. The following table summarizes restricted common stock activity: Weighted Average Number of Grant Date Shares Fair Value Fair Value Non-vested, June 30, 2021 245,252 481,953 $ 2.47 Granted 356,582 850,996 2.39 Vested (201,742) (557,496) 2.51 Forfeited — — — Non-vested, June 30, 2022 400,092 $ 775,453 $ 2.38 Granted 2,354,834 3,478,878 1.48 Vested (211,967) (1,418,717) 2.42 Forfeited (65,165) (123,953) 2.15 Non-vested, June 30, 2023 2,477,794 $ 2,711,661 $ 1.52 Common Stock Repurchase and Retirement Effective as of February 9, 2021, the Compensation Committee of our Board of Directors authorized the repurchase, during calendar year 2021 on the last day of each trading window and otherwise in accordance with our insider trading policies, of up to $400,000 of outstanding common stock (at prices no greater than $4.00 per share) from our employees to satisfy their tax obligations in connection with the vesting of stock incentive awards. The Compensation Committee of our Board of Directors subsequently approved the extension of the repurchases under the same terms through the end of fiscal year 2024. The actual number of shares repurchased will be determined by applicable employees in their discretion, and will depend on their evaluation of market conditions and other factors. As of June 30, 2022, $255,345 remained under the current authorization to repurchase our outstanding common stock from our employees. During the years ended June 30, 2023 and 2022, we repurchased 51,841 and 40,221 shares of our common stock under the repurchase plan at an average price of approximately $2.01 and $2.34 per share, respectively, for an aggregate amount of $104,250 and $93,918, respectively. As of June 30, 2023, $151,095 remains under the current authorization to repurchase our outstanding common stock from our employees. Shares repurchased are retired and deducted from common stock for par value and from additional paid in capital for the excess over par value. Direct costs incurred to acquire the shares are included in the total cost of the shares. The following table summarizes repurchases of our common stock on a monthly basis: Total Number of Shares Approximate Dollar Value Total Number Average Purchased as Part of of Shares that May Yet Be of Shares Price Paid Publicly Announced Purchased Under the Period Purchased 1 per Share Plans or Programs Plans or Programs September 2021 21,365 $ 2.55 — $ 294,782 December 2021 5,951 $ 2.24 — 281,451 March 2022 6,086 $ 2.34 — 267,210 June 2022 6,819 $ 1.74 — 255,345 Year ended June 30, 2022 40,221 $ 2.34 — $ 255,345 September 2022 9,659 $ 1.87 — $ 237,283 December 2022 16,141 $ 1.90 — 206,616 March 2023 12,785 $ 2.02 — 180,789 June 2023 13,256 $ 2.24 — 151,095 Year ended June 30, 2023 51,841 $ 2.01 — $ 151,095 1 Consists of shares of common stock purchased from employees to satisfy tax obligations in connection with the vesting of stock incentive awards .

Contingencies and Commitments

Contingencies and Commitments	12 Months Ended
Contingencies and Commitments	Jun. 30, 2023
Contingencies
Contingencies	Note 7. Contingencies and Commitments Legal Proceedings The Company is involved in legal proceedings in the ordinary course of its business. Although management of the Company cannot predict the ultimate outcome of these legal proceedings with certainty, it believes that the ultimate resolution of the Company’s legal proceedings, including any amounts it may be required to pay, will not have a material effect on the Company’s consolidated financial statements.

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Jun. 30, 2023
Income Taxes
Income Taxes	Note 8. Income Taxes The provision for income taxes consists of the following for the years ended June 30, 2023 and 2022: Years Ended June 30, 2023 2022 Current Federal $ — $ — State 3,806 3,820 Foreign (Mexico) 1,796 3,802 Deferred Federal — — Foreign — — State — — Provision for income tax expense $ 5,602 $ 7,622 During the year ended June 30, 2023, the Company recorded a provision for income tax expense of $5,602, which consisted of $3,806 in state income tax payments and $1,796 in foreign (Mexico) income tax payments. During the year ended June 30, 2022, the Company recorded a provision for income tax expense of $7,622 which consisted of $3,820 in state income tax payments and $3,802 in foreign (Mexico) income tax payments. The reconciliation of the effective income tax rate to the federal statutory rate is as follows: Years Ended June 30, 2023 2022 Federal income tax rate 21.0 % 21.0 % State tax, net of federal benefit 5.0 % 5.0 % Permanent differences (3.4) % 1.2 % Change in valuation allowance (21.8) % (27.7) % Effective income tax rate 0.8 % (0.5) % Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial statement purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities at June 30, 2023 and 2022 are as follows: June 30, June 30, 2023 2022 Deferred tax assets: Federal net operating loss carryforward $ 2,074,080 $ 2,440,870 State net operating loss carryforward 171,716 326,117 Intangibles amortization 148,404 156,196 Stock based compensation 2,250,149 1,993,124 Other 211,219 207,901 Total deferred tax assets 4,855,568 5,124,208 Deferred tax liability: Fixed asset depreciation (73,224) (51,094) Net deferred tax assets 4,782,344 5,073,114 Less valuation allowance (4,782,344) (5,073,114) $ — $ — The Company has provided a valuation allowance on the deferred tax assets at June 30, 2023 and 2022 to reduce such asset to zero, since there is no assurance that the Company will generate future taxable income to utilize such asset. Management will review this valuation allowance requirement periodically and make adjustments as warranted. The net change in the valuation allowance for the year ended June 30, 2023 was a decrease of $290,770. At June 30, 2023 and 2022, the Company had federal net operating loss (“NOL”) carryforwards of approximately $15,650,000 and $15,040,000, respectively, and state NOL carryforwards of approximately $6,560,000 and $6,420,000, respectively. Federal NOLs generated prior to and after 2018 can be carried forward indefinitely with some limitations. State NOLs, if unused, completely expire in 2039 Effective January 1, 2007, the Company adopted FASB guidelines that address the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under this guidance, we may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. This guidance also provides guidance on derecognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. At the date of adoption, and as of June 30, 2023 and 2022, the Company did not have a liability for unrecognized tax benefits, and no adjustment was required at adoption. The Company’s policy is to record interest and penalties on uncertain tax provisions as income tax expense. As of June 30, 2023 and 2022, the Company has no accrued interest or penalties related to uncertain tax positions. Company is subject to taxation in the United States and various states and Mexico. The Company is subject to United States federal or state income tax examinations by tax authorities for fiscal years after 2017.

Acquisition

Acquisition	12 Months Ended
Acquisition	Jun. 30, 2023
Acquisition
Acquisition	Note 9. Acquisition On September 28, 2022, Reprints Desk entered into an asset purchase agreement with FIZ Karlsruhe – Leibniz-Institut für Informationsinfrastruktur GmbH (“FIZ”). FIZ delivers STM content pursuant to various contracts with its customers through its AutoDoc platform. FIZ agreed to assign and transfer to Reprints Desk certain of these contracts effective January 1, 2023 (the “Sold Contracts”). On September 30, 2022, Reprints Desk made a non-refundable payment of $297,450 (€300,000) (the “Base Amount”) as initial consideration for the asset purchase. As of June 30, 2023, Reprints Desk has recorded $95,689 in contingent consideration for customers that have their Sold Contracts assumed by Reprints Desk in comparison to the trailing twelve months of revenue of all Sold Contracts (the “Base Amount Plus”). On June 30, 2023, $44,553 in contingent consideration was recorded for customers that placed an order and have consented to have their contract assumed by Reprints Desk (the “Bonus Amount”). As of the June 30, 2023, $50,509 of Bonus Amount payments were made for the 2023 fiscal year. The Bonus Amount is based upon the collectable service fee that FIZ would have received from these customers. Contingent consideration for the Bonus Amount will continue to be paid in arrears through the quarter ending December 31, 2025. The current contingent consideration for the Base Amount Plus and the Bonus Amount are recorded as a short-term liability on the balance sheet. At June 30, 2023, the Base Amount, the Base Amount Plus and the Bonus Amount were recorded as intangible assets on the balance sheet with an estimated average useful life of 10 years.

Subsequent Events

Subsequent Events	12 Months Ended
Subsequent Events	Jun. 30, 2023
Subsequent Events
Subsequent Events	Note 10. Subsequent Events Acquisition On July 28, 2023, the Company acquired 100% of the outstanding stock of Resolute Innovation, Inc. (“Resolute Innovation”), a Delaware corporation, an advanced search platform that equips organizations with search, discovery and knowledge management tools that are powered by artificial intelligence (“AI”) and neuro-linguistic programming (“NLP”) technologies. The initial purchase consideration, net of cash acquired, was approximately $2.9 million. In addition, the acquisition agreement includes an earnout that will be based upon the product of three and one Stock Options On September 1, 2023, the Company issued 3,578 shares of common stock upon the exercise of stock options underlying 17,000 shares of common stock on a cashless basis. Restricted Common Stock On August 25, 2023, the Company issued 5,000 shares of restricted stock to an employee. These shares vest over a three year period, with a one year cliff vesting period, and remain subject to forfeiture if vesting conditions are not met. The aggregate value of the stock award was $11,200 based on the market price of our common stock of $2.24 per share on the date of grant, which will be amortized over the three-year vesting period. On August 25, 2023, the Company granted, under the 2017 Plan, restricted stock awards in the amount 100,000 shares to key employees in accordance with its long-term equity bonus program (the “LTEBP”). The LTEBP spans 5 years and is designed to better serve stockholder interests by aligning key executive compensation with stockholder value. Awards under the LTEBP will vest as follows, upon the 30-day volume weighted average price (VWAP) of our common stock reaching the following targets: Upon a change of control vesting will accelerate with respect to that portion of the award that would vest if the target 30-day VWAP was achieved at the level above the per share price in such change of control transaction. For example, if we granted an award of 100,000 shares under the LTEBP, 20,000 shares would vest upon our stock price achieving a 30-day VWAP of $3.00 per share, and 20,000 shares would vest upon our stock price achieving a 30-day VWAP of $3.75 per share. If the per share price in a change of control transaction was $5.00 per share, vesting would accelerate for 40,000 shares under the same award (i.e. the number of shares that would vest for our stock price achieving a 30-day VWAP of $5.25 per share). As a condition to receiving awards under the LTEBP, recipients will be required to hold at least 75% of all vested shares during the term of their employment. Applicable target 30-day VWAPs must be achieved within 5 years following the grant of awards under the LTEBP, and all unvested awards under the LTEBP will be forfeited upon expiration of such 5-year

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Jun. 30, 2023
Summary of Significant Accounting Policies
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. These estimates and assumptions include estimates for reserves of uncollectible accounts, accruals for potential liabilities, assumptions made in valuing equity instruments issued for services or acquisitions, and realization of deferred tax assets.
Cash and Cash Equivalents	Cash and Cash Equivalents For purposes of the statements of cash flows, the Company defines cash equivalents as all highly liquid debt instruments purchased with an original maturity of three months or less. In all periods presented, cash equivalents consist primarily of money market funds.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Inputs, other than the quoted prices in active markets, are observable either directly or indirectly. Level 3 – Unobservable inputs based on the Company’s assumptions. The Company is required to use observable market data if such data is available without undue cost and effort. The Company has no fair value items required to be disclosed as of June 30, 2023 or 2022 under these requirements. The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable and accounts payable, approximate their fair values because of the short maturity of these instruments.
Allowance for Doubtful Accounts	Allowance for Doubtful Accounts The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded, which reduces the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential bad debts, bad debt charges are recorded based on the Company’s historical losses and an overall assessment of past due trade accounts receivable outstanding. The Company established an allowance for doubtful accounts of $85,015 and $94,144 as of June 30, 2023 and 2022, respectively.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents and accounts receivable. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $250,000 insurance limit. The Company does not anticipate incurring any losses related to these credit risks. The Company extends credit based on an evaluation of the customer’s financial condition, generally without collateral. Exposure to losses on receivables is principally dependent on each customer’s financial condition. The Company monitors its exposure for credit losses and intends to maintain allowances for anticipated losses, as required. Cash denominated in Euros and British Pounds with an aggregate US Dollar equivalent of $1,760,323 and $483,232 at June 30, 2023 and 2022, respectively, was held in accounts at financial institutions located in Europe. The Company has no customers that represent 10% of revenue or more for the years ended June 30, 2023 and 2022. The Company has no customers that represent 10% of accounts receivable at June 30, 2023 and 2022. The following table summarizes our content costs from our vendors: Year Ended June 30, 2023 2022 Vendor A 23 % 21 % Vendor B 13 % 13 %
Property and Equipment	Property and Equipment Property and equipment are stated at cost and are depreciated using the straight-line method over their estimated useful lives of 3 to 7 years. Leasehold improvements are amortized over the shorter of the useful lives of the related assets, or the lease term. Expenditures for maintenance and repairs are charged to operations as incurred while renewals and betterments are capitalized. Gains and losses on disposals are included in the consolidated statements of operations. Management assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended June 30, 2023 and 2022, the Company did not recognize any impairments for its property and equipment.
Revenue Recognition	Revenue Recognition The Company accounts for revenue in accordance with ASU 2014-09, Revenue from Contracts with Customers (Topic 606), (“ASC 606”). The underlying principle of ASC 606 is to recognize revenue to depict the transfer of goods or services to customers at the amount expected to be collected. Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company derives its revenues from two sources: annual licenses that allow customers to access and utilize certain premium features of our cloud-based SaaS research intelligence platform (“Platforms”) and the transactional sale of STM content managed, sourced and delivered through the Platform (“Transactions”). The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements: ● identify the contract with a customer; ● identify the performance obligations in the contract; ● determine the transaction price; ● allocate the transaction price to performance obligations in the contract; and ● recognize revenue as the performance obligation is satisfied. Platforms We charge a subscription fee that allows customers to access and utilize certain premium features of our Platform. Revenue is recognized ratably over the term of the subscription agreement, which is typically one year, provided all other revenue recognition criteria have been met. Billings or payments received in advance of revenue recognition are recorded as deferred revenue. Transactions We charge a transactional service fee for the electronic delivery of single articles, and a corresponding copyright fee for the permitted use of the content. We recognize revenue from single article delivery services upon delivery to the customer provided all other revenue recognition criteria have been met. Revenue by Geographical Region The following table summarizes revenue by geographical region: Year Ended June 30, 2023 2022 United States $ 21,862,582 58.0 % $ 19,170,684 58.2 % Europe 12,716,650 33.7 % 11,432,516 34.7 % Rest of World 3,124,220 8.3 % 2,330,952 7.1 % Total $ 37,703,452 100 % $ 32,934,152 100 % Accounts Receivable by Geographical Region The following table summarizes accounts receivable by geographical region: Year Ended June 30, 2023 2022 United States $ 3,727,977 60.6 % $ 3,255,976 62.0 % Europe 1,763,044 28.7 % 1,665,111 31.7 % Rest of World 662,042 10.8 % 330,458 6.3 % Total $ 6,153,063 100 % $ 5,251,545 100 %
Cost of Revenue	Cost of Revenue Platforms Cost of Platform revenue consists primarily of personnel costs of our operations team, and to a lesser extent managed hosting providers and other third-party service and data providers. Transactions Cost of Transaction revenue consists primarily of the respective copyright fee for the permitted use of the content, less a discount in most cases, and to a much lesser extent, personnel costs of our operations team and third-party service providers.
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock options, warrants and restricted stock to employees and non-employees for services, in capital raising transactions, and for financing costs. The Company accounts for share-based payments under the guidance as set forth in the Share-Based Payment Topic 718 of the FASB Accounting Standards Codification, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, officers, directors, and consultants, including employee stock options, based on estimated fair values. The Company estimates the fair value of stock option and warrant awards to employees and directors on the date of grant using an option-pricing model, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company’s Statements of Operations. The Company estimates the fair value of restricted stock awards to employees and directors using the market price of the Company’s common stock on the date of grant, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company’s Statements of Operations. Under ASC 718, Repurchase or Cancellation of equity awards, the amount of cash or other assets transferred (or liabilities incurred) to repurchase an equity award shall be charged to equity, to the extent that the amount paid does not exceed the fair value of the equity instruments repurchased at the repurchase date. Any excess of the repurchase price over the fair value of the instruments repurchased shall be recognized as additional compensation cost.
Foreign Currency	Foreign Currency The accompanying consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the period. Although the majority of our revenue and costs are in US dollars, the costs of Reprints Desk Latin America and ResSoL LA are in Mexican Pesos. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities. Gains and losses from foreign currency transactions, which result from a change in exchange rates between the functional currency and the currency in which a foreign currency transaction is denominated, are included in selling, general and administrative expenses and amounted to a gain of $121,953 and a loss of $143,898 for the years ended June 30, 2023 and 2022, respectively. Cash denominated in Euros and British Pounds with an aggregate US Dollar equivalent of $1,760,323 and $483,232 at June 30, 2023 and 2022, respectively, was held in accounts at financial institutions located in Europe. The following table summarizes the exchange rates used: Year Ended June 30, 2023 2022 Period end Euro : US Dollar exchange rate 1.09 1.05 Average period Euro : US Dollar exchange rate 1.05 1.13 Period end GBP : US Dollar exchange rate 1.27 1.21 Average period GBP : US Dollar exchange rate 1.20 1.34 Period end Mexican Peso : US Dollar exchange rate 0.06 0.05 Average period Mexican Peso : US Dollar exchange rate 0.05 0.05
Net Income (Loss) Per Share	Net Income (Loss) Per Share Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive. At June 30, 2023 potentially dilutive securities include options to acquire 2,909,574 shares of common stock and unvested restricted common stock of 2,477,794. At June 30, 2022 potentially dilutive securities include options to acquire 3,182,872 shares of common stock and unvested restricted common stock of 400,092. The dilutive effect of potentially dilutive securities is reflected in diluted net income per share if the exercise prices were lower than the average fair market value of common shares during the reporting period. Basic and diluted net loss per common share is the same for the year ended June 30, 2022 because all stock options, warrants, and unvested restricted common stock are anti-dilutive. For the year ended June 30, 2023, the calculation of diluted earnings per share include unvested restricted common stock, stock options and warrants, calculated under the treasury stock method.
Income Taxes	Income Taxes The Company accounts for income taxes using the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses (“CECL”) to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. ASU 2016-13 is effective for the Company beginning July 1, 2023, and early adoption is permitted. The Company does not believe the potential impact of the new guidance and related codification improvements will be material to its financial position, results of operations and cash flows. Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
Summary of Significant Accounting Policies (Tables)	Jun. 30, 2023
Summary of Significant Accounting Policies
Schedule of vendor concentration risk percentage	Year Ended June 30, 2023 2022 Vendor A 23 % 21 % Vendor B 13 % 13 %
Schedule of revenue by geographical region	Year Ended June 30, 2023 2022 United States $ 21,862,582 58.0 % $ 19,170,684 58.2 % Europe 12,716,650 33.7 % 11,432,516 34.7 % Rest of World 3,124,220 8.3 % 2,330,952 7.1 % Total $ 37,703,452 100 % $ 32,934,152 100 %
Schedule of accounts receivable by geographical region	Year Ended June 30, 2023 2022 United States $ 3,727,977 60.6 % $ 3,255,976 62.0 % Europe 1,763,044 28.7 % 1,665,111 31.7 % Rest of World 662,042 10.8 % 330,458 6.3 % Total $ 6,153,063 100 % $ 5,251,545 100 %
Schedule of foreign currency exchange rate	The following table summarizes the exchange rates used: Year Ended June 30, 2023 2022 Period end Euro : US Dollar exchange rate 1.09 1.05 Average period Euro : US Dollar exchange rate 1.05 1.13 Period end GBP : US Dollar exchange rate 1.27 1.21 Average period GBP : US Dollar exchange rate 1.20 1.34 Period end Mexican Peso : US Dollar exchange rate 0.06 0.05 Average period Mexican Peso : US Dollar exchange rate 0.05 0.05

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
Property and Equipment (Tables)	Jun. 30, 2023
Property and Equipment
Schedule of Property, Plant and Equipment	Property and equipment consists of the following as of June 30, 2023 and 2022: June 30, June 30, 2023 2022 Computer equipment $ 628,200 $ 566,518 Software 282,080 282,080 Furniture and fixtures 41,821 40,383 Total 952,101 888,981 Less accumulated depreciation (881,908) (840,996) Net, Property and equipment $ 70,193 $ 47,985

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
Intangible Assets (Tables)	Jun. 30, 2023
Intangible Assets
Schedule of Finite-Lived Intangible Assets	June 30, June 30, 2023 2022 Customer lists $ 1,192,998 $ 706,611 Intellectual property licenses 16,425 16,425 Total 1,209,423 723,036 Less accumulated amortization (747,355) (723,036) Net, Intangible assets $ 462,068 $ —

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
Stockholders' Equity (Tables)	Jun. 30, 2023
Stockholders' Equity
Schedule of vested and unvested stock option activity	The following table summarizes vested and unvested stock option activity: All Options Vested Options Unvested Options Weighted Weighted Weighted Average Average Average Exercise Exercise Exercise Shares Price Shares Price Shares Price Outstanding at July 1, 2021 3,258,408 $ 1.68 2,930,474 $ 1.60 327,934 $ 2.46 Granted 307,843 2.22 — — 307,843 2.22 Options vesting — — 452,879 2.26 (452,879) 2.26 Exercised (357,079) 1.20 (357,079) 1.20 — — Forfeited (26,300) 1.34 (26,300) 1.34 — — Outstanding at June 30, 2022 3,182,872 $ 1.79 2,999,974 $ 1.75 182,898 $ 2.49 Granted 200,000 2.15 — — 200,000 2.15 Options vesting — — 336,834 2.28 (336,834) 2.28 Exercised (307,298) 1.31 (307,298) 1.31 — — Forfeited (166,000) 1.81 (163,917) 1.79 (2,083) 3.92 Outstanding at June 30, 2023 2,909,574 $ 1.87 2,865,593 $ 1.86 43,981 $ 2.47
Schedule of valuation assumptions	The following table presents the assumptions used to estimate the fair values based upon a Black-Scholes option pricing model of the stock options granted during the years ended June 30, 2023 and 2022. Years Ended June 30, 2023 2022 Expected dividend yield — % — % Risk-free interest rate 3.76 % 0.92 - 1.81 % Expected life (in years) 5 5 - 6 Expected volatility 56 % 56 %
Schedule of additional information regarding stock options outstanding and exercisable	Additional information regarding stock options outstanding and exercisable as of June 30, 2023 is as follows: Option Remaining Exercise Options Contractual Options Price Outstanding Life (in years) Exercisable $ 0.70 225,000 2.43 225,000 0.77 25,000 1.14 25,000 0.80 16,000 2.14 16,000 0.90 15,000 2.10 15,000 1.00 15,000 1.70 15,000 1.05 305,000 3.15 305,000 1.09 40,000 2.90 40,000 1.10 105,000 2.00 105,000 1.20 274,000 4.05 274,000 1.59 25,000 4.87 25,000 1.80 54,550 0.23 54,550 1.95 200,000 5.01 200,000 2.10 238,767 8.62 238,767 2.13 216,708 7.39 215,316 2.15 200,000 9.45 200,000 2.17 35,955 7.87 26,965 2.19 5,000 8.56 2,500 2.40 302,833 5.38 302,833 2.43 61,250 7.93 53,750 2.45 163,000 7.10 163,000 2.49 78,435 6.92 76,195 2.50 20,000 5.88 20,000 2.64 30,882 8.10 20,588 2.67 33,194 8.22 22,129 2.99 8,000 6.87 8,000 3.13 208,000 6.38 208,000 3.50 8,000 6.62 8,000 Total 2,909,574 2,865,593
Schedule of warrant activity	The following table summarizes warrant activity: Weighted Average Number of Exercise Warrants Price Outstanding, June 30, 2021 50,000 $ 1.19 Granted — — Exercised (50,000) 1.19 Repurchased — — Expired/Cancelled — — Outstanding, June 30, 2022 — $ — Granted — — Exercised — — Repurchased — — Expired/Cancelled — — Outstanding, June 30, 2023 — $ — Exercisable, June 30, 2022 — $ — Exercisable, June 30, 2023 — $ —
Schedule of restricted common stock activity	The following table summarizes restricted common stock activity: Weighted Average Number of Grant Date Shares Fair Value Fair Value Non-vested, June 30, 2021 245,252 481,953 $ 2.47 Granted 356,582 850,996 2.39 Vested (201,742) (557,496) 2.51 Forfeited — — — Non-vested, June 30, 2022 400,092 $ 775,453 $ 2.38 Granted 2,354,834 3,478,878 1.48 Vested (211,967) (1,418,717) 2.42 Forfeited (65,165) (123,953) 2.15 Non-vested, June 30, 2023 2,477,794 $ 2,711,661 $ 1.52
Schedule of Repurchase Agreements	The following table summarizes repurchases of our common stock on a monthly basis: Total Number of Shares Approximate Dollar Value Total Number Average Purchased as Part of of Shares that May Yet Be of Shares Price Paid Publicly Announced Purchased Under the Period Purchased 1 per Share Plans or Programs Plans or Programs September 2021 21,365 $ 2.55 — $ 294,782 December 2021 5,951 $ 2.24 — 281,451 March 2022 6,086 $ 2.34 — 267,210 June 2022 6,819 $ 1.74 — 255,345 Year ended June 30, 2022 40,221 $ 2.34 — $ 255,345 September 2022 9,659 $ 1.87 — $ 237,283 December 2022 16,141 $ 1.90 — 206,616 March 2023 12,785 $ 2.02 — 180,789 June 2023 13,256 $ 2.24 — 151,095 Year ended June 30, 2023 51,841 $ 2.01 — $ 151,095 1 Consists of shares of common stock purchased from employees to satisfy tax obligations in connection with the vesting of stock incentive awards .

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Jun. 30, 2023
Income Taxes
Schedule of provision for income taxes	The provision for income taxes consists of the following for the years ended June 30, 2023 and 2022: Years Ended June 30, 2023 2022 Current Federal $ — $ — State 3,806 3,820 Foreign (Mexico) 1,796 3,802 Deferred Federal — — Foreign — — State — — Provision for income tax expense $ 5,602 $ 7,622
Schedule of reconciliation of the effective income tax rate	The reconciliation of the effective income tax rate to the federal statutory rate is as follows: Years Ended June 30, 2023 2022 Federal income tax rate 21.0 % 21.0 % State tax, net of federal benefit 5.0 % 5.0 % Permanent differences (3.4) % 1.2 % Change in valuation allowance (21.8) % (27.7) % Effective income tax rate 0.8 % (0.5) %
Schedule of deferred tax assets and liabilities	June 30, June 30, 2023 2022 Deferred tax assets: Federal net operating loss carryforward $ 2,074,080 $ 2,440,870 State net operating loss carryforward 171,716 326,117 Intangibles amortization 148,404 156,196 Stock based compensation 2,250,149 1,993,124 Other 211,219 207,901 Total deferred tax assets 4,855,568 5,124,208 Deferred tax liability: Fixed asset depreciation (73,224) (51,094) Net deferred tax assets 4,782,344 5,073,114 Less valuation allowance (4,782,344) (5,073,114) $ — $ —

Organization, Nature of Busin_2

Organization, Nature of Business and Basis of Presentation (Details)	12 Months Ended
	Jun. 30, 2023 item subsidiary
Organization, Nature of Business and Basis of Presentation
Number of subsidiaries \| subsidiary	3
Number of service offerings	2
Number of existing STM articles on the platform	80,000,000
Number of newly published STM articles each year.	1,000,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details)	12 Months Ended
	Jun. 30, 2023 USD ($) item shares	Jun. 30, 2022 USD ($) shares
Allowance for doubtful accounts	$ 85,015	$ 94,144
FDIC insured amount	250,000
Cash and cash equivalents	$ 13,545,333	10,603,175
Antidilutive securities amount \| shares	2,477,794
Foreign currency transaction gain (loss)	$ 121,953	$ (143,898)
Number of revenue streams \| item	2
Employee stock options
Antidilutive securities amount \| shares	2,909,574	3,182,872
Restricted Common Stock
Antidilutive securities amount \| shares	2,477,794	400,092
Maximum
Property and equipment estimated useful lives	7 years
Minimum
Property and equipment estimated useful lives	3 years
Europe financial institutions
Cash and cash equivalents	$ 1,760,323	$ 483,232

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Concentrations (Details) - Content costs from vendors - Supplier Concentration	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Vendor A
Concentration percentage	23%	21%
Vendor B
Concentration percentage	13%	13%

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Revenue (Details) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Revenues	$ 37,703,452	$ 32,934,152
Percentage of revenue	100%	100%
Accounts receivable
Revenues	$ 6,153,063	$ 5,251,545
Percentage of revenue	100%	100%
United States
Revenues	$ 21,862,582	$ 19,170,684
Percentage of revenue	58%	58.20%
United States \| Accounts receivable
Revenues	$ 3,727,977	$ 3,255,976
Percentage of revenue	60.60%	62%
Europe
Revenues	$ 12,716,650	$ 11,432,516
Percentage of revenue	33.70%	34.70%
Europe \| Accounts receivable
Revenues	$ 1,763,044	$ 1,665,111
Percentage of revenue	28.70%	31.70%
Rest of World
Revenues	$ 3,124,220	$ 2,330,952
Percentage of revenue	8.30%	7.10%
Rest of World \| Accounts receivable
Revenues	$ 662,042	$ 330,458
Percentage of revenue	10.80%	6.30%

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Exchange rates (Details)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Euro to US Dollar
Period end exchange rate	1.09	1.05
Average period exchange rate	1.05	1.13
GBP To US Dollar
Period end exchange rate	1.27	1.21
Average period exchange rate	1.20	1.34
Mexican Peso to US Dollar
Period end exchange rate	0.06	0.05
Average period exchange rate	0.05	0.05

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Total	$ 952,101	$ 888,981
Less accumulated depreciation	(881,908)	(840,996)
Net, Property and equipment	70,193	47,985
Computer equipment
Total	628,200	566,518
Software
Total	282,080	282,080
Furniture and fixtures
Total	$ 41,821	$ 40,383

Property and Equipment - Additi

Property and Equipment - Additional Information (Details) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Property and Equipment
Depreciation	$ 28,329	$ 17,651

Intangible Assets (Details)

Intangible Assets (Details) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Total	$ 1,209,423	$ 723,036
Less accumulated amortization	(747,355)	(723,036)
Net, Intangible assets	462,068	0
Customer lists
Finite-Lived Intangible Assets [Line Items]
Total	1,192,998	706,611
Intellectual property licenses
Finite-Lived Intangible Assets [Line Items]
Total	$ 16,425	$ 16,425

Intangible Assets - Additional

Intangible Assets - Additional Information (Details) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Intangible Assets
Amortization of Intangible Assets	$ 24,320	$ 0
Estimated useful life	10 years
Expected amortization in 2024 through 2028	$ 49,000
Expected amortization, thereafter	$ 217,000

Line of Credit (Details)

Line of Credit (Details)		12 Months Ended
Line of Credit (Details)	Jul. 23, 2010 USD ($)	Jun. 30, 2023 USD ($) item	Feb. 28, 2023 USD ($)	Jun. 30, 2022 USD ($)
Line of credit amount	$ 2,500,000
Percentage of eligible accounts receivable	80%
Line of credit facility expiration date		Feb. 28, 2024
Covenants ratio		1.15
Fixed interest rate		5%
Interest rate on the line of credit		9.25%
Outstanding borrowings under line of credit		$ 0		$ 0
Approximate available credit		$ 2,264,000
Number of banks \| item		3
Prime Rate [Member]
Marginal interest rate		1%
Silicon Valley Bridge Bank [Member]
Cash		$ 7,580,000	$ 10,832,000
Cash, Uninsured Amount		6,443,000	$ 9,738,000
Bank of America NA [Member]
Cash		1,500,000
PNC Bank NA [Member]
Cash		$ 4,448,000

Stockholders' Equity - Options

Stockholders' Equity - Options Narrative (Details) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Nov. 17, 2021	Feb. 09, 2021	Nov. 17, 2020	Nov. 21, 2017	Nov. 10, 2016
Term number of years	5 years
Weighted average remaining contractual life of all options outstanding	5 years 5 months 26 days
Remaining contractual life for options vested and exercisable	5 years 5 months 12 days
Aggregate intrinsic value of options vested and exercisable	$ 1,096,942
Granted (in shares)	200,000	307,843
Fair value of vested stock options	$ 375,189	$ 470,615
Amount of unvested compensation related to stock options	$ 56,577	$ 212,642
Common stock issued upon exercise of stock options	307,298	357,079
Proceeds from the exercise of stock options	$ 57,500	$ 97,688
Exercise price		$ 1.19
Number of shares from exercised warrants		50,000
Employees
Number of shares of restricted common stock issued		307,843
Fair value of vested stock options		$ 342,566
Common Stock
Number of shares of restricted common stock issued	2,354,834	356,582
Granted (in shares)	137,523	211,072
Fair value of vested stock options	$ 0	$ 0
Common stock issued upon exercise of stock options	137,523	211,072
Proceeds from the exercise of stock options	$ 57,500	$ 97,688
Number of shares available from stock options	307,298	357,079
Director
Granted (in shares)	200,000
Fair value of vested stock options	$ 222,000
Employee stock options
Vesting period	3 years
Number of year(s) cliff vesting period	1 year
Term number of years	10 years
Employee stock options \| 2007 Plan
Number of shares available for grant	0
Employee stock options \| 2017 Plan
Number of shares available for grant	1,495,927					1,874,513
Minimum \| Employee stock options
Number of shares available for grant							5,000,000
Minimum \| Employee stock options \| 2017 Plan
Number of shares available for grant			3,374,513		2,374,513
Maximum
Share price				$ 4
Maximum \| Employee stock options
Number of shares available for grant							7,000,000
Maximum \| Employee stock options \| 2017 Plan
Number of shares available for grant			6,874,513		3,374,513

Stockholders' Equity - Stock op

Stockholders' Equity - Stock option Activity (Details) - $ / shares	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Outstanding beginning balance (in shares)	3,182,872	3,258,408
Granted (in shares)	200,000	307,843
Options vesting (in shares)	0	0
Exercised (in shares)	(307,298)	(357,079)
Forfeited (in shares)	(166,000)	(26,300)
Outstanding ending balance (in shares)	2,909,574	3,182,872
Outstanding beginning balance Weighted Average Exercise Price	$ 1.79	$ 1.68
Granted Weighted Average Exercise Price	2.15	2.22
Options vesting Weighted Average Exercise Price	0	0
Exercised Weighted Average Exercise Price	1.31	1.20
Forfeited Weighted Average Exercise Price	1.81	1.34
Outstanding ending balance Weighted Average Exercise Price	$ 1.87	$ 1.79
Vested Options [Member]
Outstanding beginning balance (in shares)	2,999,974	2,930,474
Granted (in shares)	0	0
Options vesting (in shares)	336,834	452,879
Exercised (in shares)	(307,298)	(357,079)
Forfeited (in shares)	(163,917)	(26,300)
Outstanding ending balance (in shares)	2,865,593	2,999,974
Outstanding beginning balance Weighted Average Exercise Price	$ 1.75	$ 1.60
Granted Weighted Average Exercise Price	0	0
Options vesting Weighted Average Exercise Price	2.28	2.26
Exercised Weighted Average Exercise Price	1.31	1.20
Forfeited Weighted Average Exercise Price	1.79	1.34
Outstanding ending balance Weighted Average Exercise Price	$ 1.86	$ 1.75
Unvested Options [Member]
Outstanding beginning balance (in shares)	182,898	327,934
Granted (in shares)	200,000	307,843
Options vesting (in shares)	336,834	(452,879)
Exercised (in shares)	0	0
Forfeited (in shares)	(2,083)	0
Outstanding ending balance (in shares)	43,981	182,898
Outstanding beginning balance Weighted Average Exercise Price	$ 2.49	$ 2.46
Granted Weighted Average Exercise Price	2.15	2.22
Options vesting Weighted Average Exercise Price	2.28	2.26
Exercised Weighted Average Exercise Price	0	0
Forfeited Weighted Average Exercise Price	3.92	0
Outstanding ending balance Weighted Average Exercise Price	$ 2.47	$ 2.49

Stockholders' Equity - Valuatio

Stockholders' Equity - Valuation assumptions (Details)	12 Months Ended
Stockholders' Equity - Valuation assumptions (Details)	Jun. 30, 2023	Jun. 30, 2022
Minimum
Expected life (in years)	1 year 4 months 9 days
Maximum
Expected life (in years)	2 years 7 months 2 days
Employee stock options
Risk-free interest rate	3.76%
Expected life (in years)	5 years
Expected volatility	56%	56%
Employee stock options \| Minimum
Risk-free interest rate		0.92%
Expected life (in years)		5 years
Employee stock options \| Maximum
Risk-free interest rate		1.81%
Expected life (in years)		6 years

Stockholders' Equity - Stock _2

Stockholders' Equity - Stock options by exercise price (Details)	12 Months Ended
	Jun. 30, 2023 $ / shares shares
Options Outstanding	2,909,574
Options Exercisable	2,865,593
Range One
Option Exercise Price \| $ / shares	$ 0.70
Options Outstanding	225,000
Remaining Contractual Life (in years)	2 years 5 months 4 days
Options Exercisable	225,000
Range Two
Option Exercise Price \| $ / shares	$ 0.77
Options Outstanding	25,000
Remaining Contractual Life (in years)	1 year 1 month 20 days
Options Exercisable	25,000
Range Three
Option Exercise Price \| $ / shares	$ 0.80
Options Outstanding	16,000
Remaining Contractual Life (in years)	2 years 1 month 20 days
Options Exercisable	16,000
Range Four
Option Exercise Price \| $ / shares	$ 0.90
Options Outstanding	15,000
Remaining Contractual Life (in years)	2 years 1 month 6 days
Options Exercisable	15,000
Range Five
Option Exercise Price \| $ / shares	$ 1
Options Outstanding	15,000
Remaining Contractual Life (in years)	1 year 8 months 12 days
Options Exercisable	15,000
Range Six
Option Exercise Price \| $ / shares	$ 1.05
Options Outstanding	305,000
Remaining Contractual Life (in years)	3 years 1 month 24 days
Options Exercisable	305,000
Range Seven
Option Exercise Price \| $ / shares	$ 1.09
Options Outstanding	40,000
Remaining Contractual Life (in years)	2 years 10 months 24 days
Options Exercisable	40,000
Range Eight
Option Exercise Price \| $ / shares	$ 1.10
Options Outstanding	105,000
Remaining Contractual Life (in years)	2 years
Options Exercisable	105,000
Range Nine
Option Exercise Price \| $ / shares	$ 1.20
Options Outstanding	274,000
Remaining Contractual Life (in years)	4 years 18 days
Options Exercisable	274,000
Range Ten
Option Exercise Price \| $ / shares	$ 1.59
Options Outstanding	25,000
Remaining Contractual Life (in years)	4 years 10 months 13 days
Options Exercisable	25,000
Range Eleven
Option Exercise Price \| $ / shares	$ 1.80
Options Outstanding	54,550
Remaining Contractual Life (in years)	2 months 23 days
Options Exercisable	54,550
Range Twelve
Option Exercise Price \| $ / shares	$ 1.95
Options Outstanding	200,000
Remaining Contractual Life (in years)	5 years 3 days
Options Exercisable	200,000
Range Thirteen
Option Exercise Price \| $ / shares	$ 2.10
Options Outstanding	238,767
Remaining Contractual Life (in years)	8 years 7 months 13 days
Options Exercisable	238,767
Range Fourteen
Option Exercise Price \| $ / shares	$ 2.13
Options Outstanding	216,708
Remaining Contractual Life (in years)	7 years 4 months 20 days
Options Exercisable	215,316
Range Fifteen
Option Exercise Price \| $ / shares	$ 2.15
Options Outstanding	200,000
Remaining Contractual Life (in years)	9 years 5 months 12 days
Options Exercisable	200,000
Range Sixteen
Option Exercise Price \| $ / shares	$ 2.17
Options Outstanding	35,955
Remaining Contractual Life (in years)	7 years 10 months 13 days
Options Exercisable	26,965
Range Seventeen
Option Exercise Price \| $ / shares	$ 2.19
Options Outstanding	5,000
Remaining Contractual Life (in years)	8 years 6 months 21 days
Options Exercisable	2,500
Range Eighteen
Option Exercise Price \| $ / shares	$ 2.40
Options Outstanding	302,833
Remaining Contractual Life (in years)	5 years 4 months 17 days
Options Exercisable	302,833
Range Nineteen
Option Exercise Price \| $ / shares	$ 2.43
Options Outstanding	61,250
Remaining Contractual Life (in years)	7 years 11 months 4 days
Options Exercisable	53,750
Range Twenty
Option Exercise Price \| $ / shares	$ 2.45
Options Outstanding	163,000
Remaining Contractual Life (in years)	7 years 1 month 6 days
Options Exercisable	163,000
Range Twenty One
Option Exercise Price \| $ / shares	$ 2.49
Options Outstanding	78,435
Remaining Contractual Life (in years)	6 years 11 months 1 day
Options Exercisable	76,195
Range Twenty Two
Option Exercise Price \| $ / shares	$ 2.50
Options Outstanding	20,000
Remaining Contractual Life (in years)	5 years 10 months 17 days
Options Exercisable	20,000
Range Twenty Three
Option Exercise Price \| $ / shares	$ 2.64
Options Outstanding	30,882
Remaining Contractual Life (in years)	8 years 1 month 6 days
Options Exercisable	20,588
Range Twenty Four
Option Exercise Price \| $ / shares	$ 2.67
Options Outstanding	33,194
Remaining Contractual Life (in years)	8 years 2 months 19 days
Options Exercisable	22,129
Range Twenty Five
Option Exercise Price \| $ / shares	$ 2.99
Options Outstanding	8,000
Remaining Contractual Life (in years)	6 years 10 months 13 days
Options Exercisable	8,000
Range Twenty Six
Option Exercise Price \| $ / shares	$ 3.13
Options Outstanding	208,000
Remaining Contractual Life (in years)	6 years 4 months 17 days
Options Exercisable	208,000
Range Twenty Seven
Option Exercise Price \| $ / shares	$ 3.50
Options Outstanding	8,000
Remaining Contractual Life (in years)	6 years 7 months 13 days
Options Exercisable	8,000

Stockholders' Equity - Warrant

Stockholders' Equity - Warrant activity (Details) - USD ($)	12 Months Ended
Stockholders' Equity - Warrant activity (Details) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Proceeds from the exercise of warrants	$ 0	$ 59,500
Warrant
Non-vested, Beginning balance		50,000
Exercised		(50,000)
Outstanding, Beginning balance Weighted Average Exercise Price		$ 1.19
Exercised Weighted Average Exercise Price		$ 1.19

Stockholders' Equity - Restrict

Stockholders' Equity - Restricted Common Stock Narrative (Details) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2020	Jun. 30, 2021
Common stock issued upon exercise of stock options	307,298	357,079
Term number of years	5 years
Percentage of All Vested Shares Recipient Is Required To Hold During Employment In Order To Receive Award	75%
Granted (in shares)	200,000	307,843
Fair value of vested restricted common stock	$ 1,418,718	$ 557,496
Antidilutive securities amount	2,477,794
Employees
Number of shares of restricted common stock issued		307,843
Minimum
Expected life (in years)	1 year 4 months 9 days
Maximum
Expected life (in years)	2 years 7 months 2 days
Restricted common stock
Number of shares of restricted common stock issued	2,354,834	356,582	2,473,176
Fair value of restricted common stock	$ 1,418,717	$ 557,496
Fair value of shares vested	2,975,400
Forfeited, Fair Value	$ (123,953)
Forfeited, Number of shares	(65,165)
Amount recognized as expense related to stock issuance			$ 2,503,245
Non-vested stock	$ 2,711,661	$ 775,453	$ 481,953	$ 481,953
Balance of non-vested shares	2,477,794	400,092	245,252	245,252
Granted Weighted Average Grant Date Fair Value	$ 1.48	$ 2.39
Term number of years	5 years
Restricted stock to employees vested	211,967	201,742
Fair value of vested restricted common stock	$ 3,478,878	$ 850,996	$ 2,985,198
Restricted common stock \| 2017 Plan
Number of shares of restricted common stock issued	2,100,000
Restricted common stock \| Minimum
Stock Repurchased Average Price Per Share	$ 1.94	$ 1.87
Vesting period	3 years
Restricted common stock \| Maximum
Stock Repurchased Average Price Per Share	$ 2.22	$ 2.64
Vesting period	4 years
Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period One [Member}
Number of shares of restricted common stock issued	100,000
Vesting percentage	20%
Volume Weighted Average Stock Price Per Share	$ 3
Restricted stock to employees vested	20,000
Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period One [Member} \| Restricted common stock
Number of shares of restricted common stock issued	2,100,000
Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period Two [Member}
Vesting percentage	20%
Volume Weighted Average Stock Price Per Share	$ 3.75
Restricted stock to employees vested	20,000
Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period Three [Member}
Vesting percentage	20%
Volume Weighted Average Stock Price Per Share	$ 4.50
Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period Four [Member}
Vesting percentage	20%
Volume Weighted Average Stock Price Per Share	$ 5.25
Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period Five [Member}
Vesting percentage	20%
Volume Weighted Average Stock Price Per Share	$ 6
Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period Six [Member}
Volume Weighted Average Stock Price Per Share	$ 5
Restricted stock to employees vested	40,000
Vest Over Three Year Period One \| Restricted common stock
Number of shares of restricted common stock issued	229,834	256,582
Vesting period	3 years	3 years
Number of year(s) cliff vesting period	1 year	1 year
Vest Over Four Year Period \| Restricted common stock
Number of shares of restricted common stock issued	25,000	100,000
Vesting period	4 years	4 years
Number of year(s) cliff vesting period	1 year	1 year
Vest Over Three and Four Year Period \| Restricted common stock
Fair value of vested restricted common stock	$ 503,478

Stockholders' Equity - Restri_2

Stockholders' Equity - Restricted common stock (Details) - Restricted common stock - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Non-vested, Beginning balance	400,092	245,252
Granted Number of shares	2,354,834	356,582
Vested, Number of shares	(211,967)	(201,742)
Forfeited, Number of shares	(65,165)
Non-vested, Ending balance	2,477,794	400,092
Non-vested, Beginning balance	$ 775,453	$ 481,953
Granted, Fair Value	3,478,878	850,996
Vested, Fair Value	(1,418,717)	(557,496)
Forfeited, Fair Value	(123,953)
Non-vested, Ending balance	$ 2,711,661	$ 775,453
Non-vested, Beginning Balance Weighted Average Grant Date Fair Value	$ 2.38	$ 2.47
Granted Weighted Average Grant Date Fair Value	1.48	2.39
Vested Weighted Average Grant Date Fair Value	2.42	2.51
Forfeited Weighted Average Grant Date Fair Value	2.15
Non-vested, Ending Balance Weighted Average Grant Date Fair Value	1.52	2.38
Minimum
Stock Repurchased Average Price Per Share	1.94	1.87
Maximum
Stock Repurchased Average Price Per Share	$ 2.22	$ 2.64

Stockholders' Equity - Repurcha

Stockholders' Equity - Repurchases of our common stock (Details) - USD ($)	1 Months Ended								12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2023	Jun. 30, 2022	Feb. 09, 2021
Amount of stock authorized for repurchase	$ 151,095								$ 151,095
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs	$ 151,095	$ 180,789	$ 206,616	$ 237,283	$ 255,345	$ 267,210	$ 281,451	$ 294,782	$ 151,095	$ 255,345
Total Number of Shares Purchased	13,256	12,785	16,141	9,659	6,819	6,086	5,951	21,365	51,841	40,221
Average Price Paid per Share	$ 2.24	$ 2.02	$ 1.90	$ 1.87	$ 1.74	$ 2.34	$ 2.24	$ 2.55	$ 2.01	$ 2.34
Repurchase of common stock									$ (104,250)	$ (93,918)
Publicly Announced Plans Or Programs
Total Number of Shares Purchased	0	0	0	0	0	0	0	0	0	0
Maximum
Amount of stock authorized for repurchase											$ 400,000
Share Price											$ 4
Common Stock
Total Number of Shares Purchased									51,841	40,221
Repurchase of common stock									$ (52)	$ (40)

Income Taxes - Provision for in

Income Taxes - Provision for income taxes (Details) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Current
Federal	$ 0	$ 0
State	3,806	3,820
Foreign (Mexico)	1,796	3,802
Deferred
Federal	0	0
Foreign	0	0
State	0	0
Provision for income tax expense	$ 5,602	$ 7,622

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of the effective income tax rate (Details)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Income Taxes
Federal income tax rate	21%	21%
State tax, net of federal benefit	5%	5%
Permanent differences	(3.40%)	1.20%
Change in valuation allowance	(21.80%)	(27.70%)
Effective income tax rate	0.80%	(0.50%)

Income Taxes - Significant comp

Income Taxes - Significant components of the Company's deferred tax assets and liabilities (Details) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Deferred tax assets:
Federal net operating loss carryforward	$ 2,074,080	$ 2,440,870
State net operating loss carryforward	171,716	326,117
Intangibles amortization	148,404	156,196
Stock based compensation	2,250,149	1,993,124
Other	211,219	207,901
Total deferred tax assets	4,855,568	5,124,208
Deferred tax liability:
Fixed asset depreciation	(73,224)	(51,094)
Net deferred tax assets	4,782,344	5,073,114
Less valuation allowance	(4,782,344)	(5,073,114)
Deferred tax assets, net	$ 0	$ 0

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($)	12 Months Ended
Income Taxes - Additional Information (Details) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Provision for income tax expense	$ 5,602	$ 7,622
State income tax payments	3,806	3,820
Foreign (Mexico) income tax payments	1,796	3,802
Increase (decrease) in valuation allowance	(290,770)
Accrued interest or penalties related to uncertain tax positions	0	0
Domestic Tax Authority
Federal net operating loss carryforwards	15,650,000	15,040,000
State and Local Jurisdiction
Federal net operating loss carryforwards	$ 6,560,000	$ 6,420,000
Expiration date of NOLs	Dec. 31, 2039

Acquisition (Details)

Acquisition (Details)			12 Months Ended
Acquisition (Details)	Sep. 30, 2022 USD ($)	Sep. 30, 2022 EUR (€)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 UYU ($)
Asset Acquisition, Contingent Consideration [Line Items]
Payment for non-refundable deposit for asset acquisition	$ 297,450	€ 300,000	$ 297,450	$ 0
Payment of bonus amount			$ 50,509
Estimated average useful life			10 years
Base Amount Plus
Asset Acquisition, Contingent Consideration [Line Items]
Contingent consideration			$ 95,689
Bonus Amount
Asset Acquisition, Contingent Consideration [Line Items]
Contingent consideration					$ 44,553

Subsequent Events (Details)

Subsequent Events (Details)					12 Months Ended
Subsequent Events (Details)	Sep. 01, 2023 shares	Aug. 25, 2023 $ / shares	Aug. 25, 2023 UYU ($) shares	Jul. 28, 2023 USD ($)	Jun. 30, 2023 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2020 USD ($) shares
Common stock issued upon exercise of stock options					307,298	357,079
Fair value of vested restricted common stock \| $					$ 1,418,718	$ 557,496
Term number of years					5 years
Percentage of all vested shares recipient is required to hold during employment in order to receive award					75%
Employees
Number of shares of restricted common stock issued						307,843
Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period One [Member}
Number of shares of restricted common stock issued					100,000
Vesting percentage					20%
Volume Weighted Average Stock Price Per Share \| $ / shares					$ 3
Restricted stock to employees vested					20,000
Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period Two [Member}
Vesting percentage					20%
Volume Weighted Average Stock Price Per Share \| $ / shares					$ 3.75
Restricted stock to employees vested					20,000
Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period Three [Member}
Vesting percentage					20%
Volume Weighted Average Stock Price Per Share \| $ / shares					$ 4.50
Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period Four [Member}
Vesting percentage					20%
Volume Weighted Average Stock Price Per Share \| $ / shares					$ 5.25
Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period Five [Member}
Vesting percentage					20%
Volume Weighted Average Stock Price Per Share \| $ / shares					$ 6
Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period Six [Member}
Volume Weighted Average Stock Price Per Share \| $ / shares					$ 5
Restricted stock to employees vested					40,000
Subsequent Event
Common stock issued upon exercise of stock options	17,000
Number of shares of restricted common stock issued			5,000
Term number of years			5 years
Percentage of all vested shares recipient is required to hold during employment in order to receive award			75%
Subsequent Event \| 2017 Plan
Number of shares of restricted common stock issued			100,000
Subsequent Event \| Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period One [Member}
Number of shares of restricted common stock issued			100,000
Vesting percentage			20%
Volume Weighted Average Stock Price Per Share \| $ / shares		$ 3
Restricted stock to employees vested			20,000
Subsequent Event \| Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period Two [Member}
Vesting percentage			20%
Volume Weighted Average Stock Price Per Share \| $ / shares		3.75
Restricted stock to employees vested			20,000
Subsequent Event \| Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period Three [Member}
Vesting percentage			20%
Volume Weighted Average Stock Price Per Share \| $ / shares		4.50
Subsequent Event \| Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period Four [Member}
Vesting percentage			20%
Volume Weighted Average Stock Price Per Share \| $ / shares		5.25
Restricted stock to employees vested			40,000
Subsequent Event \| Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period Five [Member}
Vesting percentage			20%
Volume Weighted Average Stock Price Per Share \| $ / shares		6
Subsequent Event \| Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period Six [Member}
Volume Weighted Average Stock Price Per Share \| $ / shares		5
Restricted common stock
Number of shares of restricted common stock issued					2,354,834	356,582	2,473,176
Fair value of vested restricted common stock \| $					$ 3,478,878	$ 850,996	$ 2,985,198
Granted Weighted Average Grant Date Fair Value \| $ / shares					$ 1.48	$ 2.39
Term number of years					5 years
Restricted stock to employees vested					211,967	201,742
Restricted common stock \| 2017 Plan
Number of shares of restricted common stock issued					2,100,000
Restricted common stock \| Vest Over Three Year Period One
Number of shares of restricted common stock issued					229,834	256,582
Vesting period					3 years	3 years
Number of year(s) cliff vesting period					1 year	1 year
Restricted common stock \| Volume Weighted Average Price (VWAP) of Common Stock over 30-Day Period One [Member}
Number of shares of restricted common stock issued					2,100,000
Restricted common stock \| Subsequent Event
Vesting period			3 years
Fair value of vested restricted common stock \| $			$ 11,200
Granted Weighted Average Grant Date Fair Value \| $ / shares		$ 2.24
Restricted common stock \| Subsequent Event \| 2017 Plan
Term number of years			5 years
Restricted common stock \| Subsequent Event \| Vest Over Three Year Period One
Vesting period			3 years
Number of year(s) cliff vesting period			1 year
Resolute Innovation, Inc \| Subsequent Event
Acquired percentage				100%
Initial purchase consideration, net of cash acquired \| $				$ 2,900,000
Multiplying factor for calculation of earnout				3.5
Agreed upon Enterprise Value \| $				$ 3,400,000
Common Stock
Common stock issued upon exercise of stock options					137,523	211,072
Number of shares of restricted common stock issued					2,354,834	356,582
Fair value of vested restricted common stock \| $					$ 2,355	$ 356
Common Stock \| Subsequent Event
Common stock issued upon exercise of stock options	3,578